Inventiva’s Lanifibranor On NASH Path After Phase II Success In NAFLD Patients With Diabetes

But All Eyes On NASH

 
• By Ayisha Sharma
  
tree pruned into shape of liver
The NASH Market Could Br Worth $26bn In Future • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D